Alicent的个人主页 - 老虎社区

Alicent

Alicent

暂无个人介绍

IP属地：海外

29关注

0粉丝

5主题

0勋章

2024-12-11

为何不敢把连锁酒店的名字写出来？

CleanCore Solutions, Inc. (ZONE) Launches Pilot Program with International Hotel Chain

2024-01-17

文章顶部列出的两个股票代码和这家公司毫无关系

Aviceda Announces First Patient Enrolled in Phase 2 GLYCO Clinical Trial Evaluating AVD-104 for the Treatment of Diabetic Macular Edema

2023-09-18

$Redhill Biopharma Ltd(RDHL)$ 老虎证券里的资讯没有 Yahoo Finance 里的股票新闻及时。这支股票今天获得美国 FDA 批准用于治疗幽门螺旋杆菌的简化用药方案

2020-12-17

截图里的行情如何能看到？如何能看到粉票市场的盘前盘后？

瑞幸咖啡盘前大涨44%，1.8亿美元与SEC达成和解

2020-10-16

说苹果创新缺失的恐怕是准备抄底的吧

抱歉，原内容已删除

2020-10-08

逗死了

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3547492843908436","uuid":"3547492843908436","gmtCreate":1584401261696,"gmtModify":1639640398365,"name":"Alicent","pinyin":"alicent","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/0a7b09bfad47e4ab0b7a96cdfaec4d6d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":29,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":5,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":9,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.88%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.09","exceedPercentage":"93.16%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"海外","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":380424190284304,"gmtCreate":1733918362325,"gmtModify":1733918363995,"author":{"id":"3547492843908436","authorId":"3547492843908436","name":"Alicent","avatar":"https://static.tigerbbs.com/0a7b09bfad47e4ab0b7a96cdfaec4d6d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3547492843908436","idStr":"3547492843908436"},"themes":[],"htmlText":"为何不敢把连锁酒店的名字写出来？","listText":"为何不敢把连锁酒店的名字写出来？","text":"为何不敢把连锁酒店的名字写出来？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/380424190284304","repostId":"2484620377","repostType":2,"repost":{"id":"2484620377","kind":"highlight","weMediaInfo":{"introduction":"Share your news with media, investors, and consumers with targeted distribution options from one of the world’s largest and most trusted newswires.","home_visible":1,"media_name":"GlobeNewswire","id":"1016364462","head_image":"https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a"},"pubTimestamp":1731936600,"share":"https://www.laohu8.com/m/news/2484620377?lang=&edition=full","pubTime":"2024-11-18 21:30","market":"us","language":"en","title":"CleanCore Solutions, Inc. (ZONE) Launches Pilot Program with International Hotel Chain","url":"https://stock-news.laohu8.com/highlight/detail?id=2484620377","media":"GlobeNewswire","summary":"Omaha, NE, Nov.  18, 2024  (GLOBE NEWSWIRE) -- CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or the “Company”), developer of patented technology that works as a safe and low-cost replac","content":"<html><body><p>Omaha, NE, Nov.  18, 2024  (GLOBE NEWSWIRE) -- <b><a href=\"https://laohu8.com/S/ZONE\">CleanCore Solutions</a>, Inc. (NYSE American: ZONE) </b>(“<b>CleanCore</b>” or the “<b>Company</b>”), developer of patented technology that works as a safe and low-cost replacement for traditional cleaning chemicals, today announced the launch of a pilot program with a prominent international hotel chain in one of their United States locations, following the successful installation of its solutions with a major franchisee of the hotel chain. </p> <p><b>Key highlights:</b></p> <ul><li>Pilot program includes testing CleanCore solutions, including Power Caddies, Fill Stations, Ice Treatment machines and Laundry, in a hotel located within the United States</li><li>Potential to expand throughout complete hotel chain spanning over 1,000 hotels in eight countries and three continents</li><li>ZONE boasts a successful track record with 98% of pilot programs resulting in signed contracts</li></ul> <p>This program includes a hotel based in the United States implementing CleanCore’s solutions, aiming to enhance cleaning efficiency, sustainability, and guest satisfaction. With a proven track record of pilot success, CleanCore has achieved a remarkable 98% conversion rate from pilot testing to signed contracts. This high success rate highlights the industry’s recognition of CleanCore’s capabilities in delivering cost-effective, eco-friendly solutions that meet stringent cleanliness and safety standards. CleanCore’s portfolio of cleaning products is designed to reduce environmental impact while maintaining the highest levels of performance and efficiency, positioning the company as an ideal partner for hospitality providers focused on quality and sustainability. </p> <p>“We’re proud to collaborate with such a distinguished hotel brand, bringing our advanced cleaning technologies to their hotel located in the United States with the potential to expand internationally. This collaboration follows our successful product installation with a major franchisee of the chain,” said Clayton Adams, CEO of CleanCore Solutions. “Additionally, we believe our high contract conversion rate is a testament to our commitment to innovation and to meeting the needs of our partners in creating safer, more sustainable environments.”</p> <p><b>About CleanCore Solutions</b><br/>CleanCore Solutions, Inc. (NYSE American: ZONE) is dedicated to revolutionizing cleaning and disinfection practices by harnessing the power of its patented aqueous ozone technology. The Company’s mission is to empower its customers with cost-effective, sustainable solutions that surpass traditional cleaning methods. Through innovation and commitment to excellence, CleanCore strives to create a healthier, greener future for generations to come. For more information, please visit https://www.cleancoresol.com/. </p> <p><b>Forward Looking Statements</b><br/>This press release contains information about our views of future expectations, plans, and prospects with respect to CleanCore’s business, financial condition, and results of operations that constitute or may constitute forward-looking statements. Any and all forward-looking statements are based on the management’s beliefs, assumptions, and expectations of CleanCore’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although CleanCore believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. CleanCore does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. Forward-looking statements are subject to a number of factors, risks, and uncertainties, some of which are not currently known to us, that may cause CleanCore’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the SEC.</p> <p><b>Investor Relations:</b><br/> Crescendo Communications, LLC<br/> Email: zone@crescendo-ir.com<br/> Tel: (212) 671-1020</p> <br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/ZGRhZGM5YTctY2ZlYS00YzRhLThiNjAtYTdhNTNiNzhhM2M4LTUwMDEyNDE2OQ==/tiny/CleanCore-Solutions-Inc-.png\"/></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CleanCore Solutions, Inc. (ZONE) Launches Pilot Program with International Hotel Chain</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCleanCore Solutions, Inc. (ZONE) Launches Pilot Program with International Hotel Chain\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1016364462\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">GlobeNewswire </p>\n<p class=\"h-time\">2024-11-18 21:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Omaha, NE, Nov.  18, 2024  (GLOBE NEWSWIRE) -- <b><a href=\"https://laohu8.com/S/ZONE\">CleanCore Solutions</a>, Inc. (NYSE American: ZONE) </b>(“<b>CleanCore</b>” or the “<b>Company</b>”), developer of patented technology that works as a safe and low-cost replacement for traditional cleaning chemicals, today announced the launch of a pilot program with a prominent international hotel chain in one of their United States locations, following the successful installation of its solutions with a major franchisee of the hotel chain. </p> <p><b>Key highlights:</b></p> <ul><li>Pilot program includes testing CleanCore solutions, including Power Caddies, Fill Stations, Ice Treatment machines and Laundry, in a hotel located within the United States</li><li>Potential to expand throughout complete hotel chain spanning over 1,000 hotels in eight countries and three continents</li><li>ZONE boasts a successful track record with 98% of pilot programs resulting in signed contracts</li></ul> <p>This program includes a hotel based in the United States implementing CleanCore’s solutions, aiming to enhance cleaning efficiency, sustainability, and guest satisfaction. With a proven track record of pilot success, CleanCore has achieved a remarkable 98% conversion rate from pilot testing to signed contracts. This high success rate highlights the industry’s recognition of CleanCore’s capabilities in delivering cost-effective, eco-friendly solutions that meet stringent cleanliness and safety standards. CleanCore’s portfolio of cleaning products is designed to reduce environmental impact while maintaining the highest levels of performance and efficiency, positioning the company as an ideal partner for hospitality providers focused on quality and sustainability. </p> <p>“We’re proud to collaborate with such a distinguished hotel brand, bringing our advanced cleaning technologies to their hotel located in the United States with the potential to expand internationally. This collaboration follows our successful product installation with a major franchisee of the chain,” said Clayton Adams, CEO of CleanCore Solutions. “Additionally, we believe our high contract conversion rate is a testament to our commitment to innovation and to meeting the needs of our partners in creating safer, more sustainable environments.”</p> <p><b>About CleanCore Solutions</b><br/>CleanCore Solutions, Inc. (NYSE American: ZONE) is dedicated to revolutionizing cleaning and disinfection practices by harnessing the power of its patented aqueous ozone technology. The Company’s mission is to empower its customers with cost-effective, sustainable solutions that surpass traditional cleaning methods. Through innovation and commitment to excellence, CleanCore strives to create a healthier, greener future for generations to come. For more information, please visit https://www.cleancoresol.com/. </p> <p><b>Forward Looking Statements</b><br/>This press release contains information about our views of future expectations, plans, and prospects with respect to CleanCore’s business, financial condition, and results of operations that constitute or may constitute forward-looking statements. Any and all forward-looking statements are based on the management’s beliefs, assumptions, and expectations of CleanCore’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although CleanCore believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. CleanCore does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. Forward-looking statements are subject to a number of factors, risks, and uncertainties, some of which are not currently known to us, that may cause CleanCore’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the SEC.</p> <p><b>Investor Relations:</b><br/> Crescendo Communications, LLC<br/> Email: zone@crescendo-ir.com<br/> Tel: (212) 671-1020</p> <br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/ZGRhZGM5YTctY2ZlYS00YzRhLThiNjAtYTdhNTNiNzhhM2M4LTUwMDEyNDE2OQ==/tiny/CleanCore-Solutions-Inc-.png\"/></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4161":"工业机械","ZONE":"CleanCore Solutions"},"source_url":"https://www.globenewswire.com/news-release/2024/11/18/2982795/0/en/CleanCore-Solutions-Inc-ZONE-Launches-Pilot-Program-with-International-Hotel-Chain.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2484620377","content_text":"Omaha, NE, Nov.  18, 2024  (GLOBE NEWSWIRE) -- CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or the “Company”), developer of patented technology that works as a safe and low-cost replacement for traditional cleaning chemicals, today announced the launch of a pilot program with a prominent international hotel chain in one of their United States locations, following the successful installation of its solutions with a major franchisee of the hotel chain.  Key highlights: Pilot program includes testing CleanCore solutions, including Power Caddies, Fill Stations, Ice Treatment machines and Laundry, in a hotel located within the United StatesPotential to expand throughout complete hotel chain spanning over 1,000 hotels in eight countries and three continentsZONE boasts a successful track record with 98% of pilot programs resulting in signed contracts This program includes a hotel based in the United States implementing CleanCore’s solutions, aiming to enhance cleaning efficiency, sustainability, and guest satisfaction. With a proven track record of pilot success, CleanCore has achieved a remarkable 98% conversion rate from pilot testing to signed contracts. This high success rate highlights the industry’s recognition of CleanCore’s capabilities in delivering cost-effective, eco-friendly solutions that meet stringent cleanliness and safety standards. CleanCore’s portfolio of cleaning products is designed to reduce environmental impact while maintaining the highest levels of performance and efficiency, positioning the company as an ideal partner for hospitality providers focused on quality and sustainability.  “We’re proud to collaborate with such a distinguished hotel brand, bringing our advanced cleaning technologies to their hotel located in the United States with the potential to expand internationally. This collaboration follows our successful product installation with a major franchisee of the chain,” said Clayton Adams, CEO of CleanCore Solutions. “Additionally, we believe our high contract conversion rate is a testament to our commitment to innovation and to meeting the needs of our partners in creating safer, more sustainable environments.” About CleanCore SolutionsCleanCore Solutions, Inc. (NYSE American: ZONE) is dedicated to revolutionizing cleaning and disinfection practices by harnessing the power of its patented aqueous ozone technology. The Company’s mission is to empower its customers with cost-effective, sustainable solutions that surpass traditional cleaning methods. Through innovation and commitment to excellence, CleanCore strives to create a healthier, greener future for generations to come. For more information, please visit https://www.cleancoresol.com/.  Forward Looking StatementsThis press release contains information about our views of future expectations, plans, and prospects with respect to CleanCore’s business, financial condition, and results of operations that constitute or may constitute forward-looking statements. Any and all forward-looking statements are based on the management’s beliefs, assumptions, and expectations of CleanCore’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although CleanCore believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. CleanCore does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. Forward-looking statements are subject to a number of factors, risks, and uncertainties, some of which are not currently known to us, that may cause CleanCore’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the SEC. Investor Relations: Crescendo Communications, LLC Email: zone@crescendo-ir.com Tel: (212) 671-1020","news_type":1},"isVote":1,"tweetType":1,"viewCount":82,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":263861218226416,"gmtCreate":1705454887797,"gmtModify":1705454889365,"author":{"id":"3547492843908436","authorId":"3547492843908436","name":"Alicent","avatar":"https://static.tigerbbs.com/0a7b09bfad47e4ab0b7a96cdfaec4d6d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3547492843908436","idStr":"3547492843908436"},"themes":[],"htmlText":"文章顶部列出的两个股票代码和这家公司毫无关系","listText":"文章顶部列出的两个股票代码和这家公司毫无关系","text":"文章顶部列出的两个股票代码和这家公司毫无关系","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/263861218226416","repostId":"2402156309","repostType":2,"repost":{"id":"2402156309","kind":"highlight","pubTimestamp":1704820140,"share":"https://www.laohu8.com/m/news/2402156309?lang=&edition=full","pubTime":"2024-01-10 01:09","market":"us","language":"en","title":"Aviceda Announces First Patient Enrolled in Phase 2 GLYCO Clinical Trial Evaluating AVD-104 for the Treatment of Diabetic Macular Edema","url":"https://stock-news.laohu8.com/highlight/detail?id=2402156309","media":"StreetInsider","summary":"Aviceda is advancing the development of AVD-104, a Novel Glyco-Mimetic Nanoparticle, for the treatment of Diabetic Macular Edema as an indication expansion in addition to Geographic Atrophy ; AVD-104 is currently enrolling patients with GA in the SIGLEC Phase 2/3 Trial.A multi-center, multi-dose, open-label safety and tolerability study will enroll 30 patients to evaluate a low and high dose of AVD-104, with topline results expected in Q2 2024.Aviceda Therapeutics, a private clinical-stage biotech company focused on developing next-generation immunomodulators by harnessing the power of glycobiology to alleviate chronic, non-resolving inflammation, announced today that they have enrolled the first patient in the GLYCO Phase 2 U.S. clinical trial evaluating their lead ophthalmic candidate AVD-104 for the management of diabetic macular edema . AVD-104 is an engineered glycan  nanoparticle that reduces inflammation by targeting the self-pattern recognition receptors on overly activated ret","content":"<html><body><div>\n<p>\n<i>AVD-104 is an engineered glycan (sialic acid) nanoparticle that reduces inflammation by targeting the self-pattern recognition receptors on overly activated retinal neutrophils, macrophages, and microglia, and repolarizing them to their resolution state.</i>\n</p><p>\n<i>Aviceda is advancing the development of AVD-104, a Novel Glyco-Mimetic Nanoparticle, for the treatment of Diabetic Macular Edema as an indication expansion in addition to Geographic Atrophy (lead indication); AVD-104 is currently enrolling patients with GA </i><i>in the SIGLEC Phase 2/3 Trial.</i>\n</p><p>\n<i>A multi-center, multi-dose, open-label safety and tolerability study will enroll 30 patients to evaluate a low and high dose of AVD-104, with topline results expected in Q2 2024.</i>\n</p>\n<p> CAMBRIDGE, Mass.--(BUSINESS WIRE)--\nAviceda Therapeutics, a private clinical-stage biotech company focused on developing next-generation immunomodulators by harnessing the power of glycobiology to alleviate chronic, non-resolving inflammation, announced today that they have enrolled the first patient in the GLYCO Phase 2 U.S. clinical trial evaluating their lead ophthalmic candidate AVD-104 for the management of diabetic macular edema (DME). AVD-104 is an engineered glycan (sialic acid) nanoparticle that reduces inflammation by targeting the self-pattern recognition receptors on overly activated retinal neutrophils, macrophages, and microglia, and repolarizing them to their resolution state.\n</p><p>\n<b>Ashkan Abbey, M.D.,</b> of Texas Retina Associates said, “I am honored to dose AVD-104 in the first patient in the GLYCO trial to evaluate its potentially next-generation dual mechanism of action to reduce the chronic inflammation that drives many cases of DME.”\n</p><p>\n<b>Mohamed Genead, M.D.,</b> Aviceda’s Co-founder and CEO said, “We are excited to evaluate the ability of AVD-104’s unique mechanism of action to provide DME patients with a safe treatment that may improve outcomes in eyes with DME driven by inflammatory and VEGF-mediated mechanisms.”\n</p><p>\n“AVD-104 down-regulates neutrophils and has been shown to reduce the release of inflammatory cytokines,” explained <b>David Callanan, M.D.</b><b>,</b> Aviceda’s Chief Medical Officer and Senior Vice President. “There is still a need for improvement in the treatment of DME and we believe it may offer therapeutic advantages in the management of DME, and potentially in diabetic ischemia.”\n</p><p>\nThe GLYCO Phase 2 U.S. clinical trial will evaluate the safety and treatment effects of intravitreal AVD-104 in patients with DME. This multi-center, open-label safety and tolerability study will enroll 30 patients to evaluate a low and high dose of AVD-104 with 3-month follow-up. The primary endpoint will be the incidence and severity of ocular and systemic adverse events. Secondary endpoint analyses will include standard evaluations of treatment efficacy, including macular thickness and vision. Further exploratory variables will include the potential effect of AVD-104 on macular ischemia.\n</p><p>\nFurther information regarding the GLYCO trial can be found <b>HERE</b>.\n</p><div><div><div></div></div></div><p>\n<b>About Aviceda Therapeutics and AVD-104</b>\n</p><p>\nAviceda is a private, late-stage clinical biotechnology company located in Cambridge, MA, with a proprietary HALOS™ nanotechnology platform and a clinical stage ophthalmic candidate, AVD-104, for the treatment of geographic atrophy secondary to age-related macular degeneration (AMD) and diabetic macular edema. AVD-104 is a promising intravitreal glycan-coated nanoparticle with a dual mechanism of action that modulates critical inflammatory cellular and complement pathways through 1) direct inhibition of the activity of damaging neutrophils and phagocytic macrophages and repolarization of activated macrophages to their resolution state and 2) inhibition of complement cascade amplification. AVD-104 has completed dosing in the single ascending dose Part I of the company’s Phase 2/3 SIGLEC trial, which is evaluating patients with geographic atrophy secondary to AMD. Topline three-month data from Part I is expected in early 2024 along with the initiation of Part II, which is a double-masked, randomized, active comparator trial. Part II of the Phase 2/3 trial will enroll 300 patients across U.S. clinical sites.\n</p><p>\nAlong with AVD-104, Aviceda has a broad pipeline of products in development in ophthalmology and multiple other therapeutic areas, including oncology, immunology, neurology, and fibrosis.\n</p><p>\nLearn more about Aviceda Therapeutics.\n</p><p><img src=\"https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20240109176126r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\"/><span></span></p><p><span>View source version on businesswire.com: </span><span>https://www.businesswire.com/news/home/20240109176126/en/</span></p>\n<p>\n<b>Organization Contact:\n</b>Aviceda Therapeutics Inc.\n<span>[email protected]</span>\n</p>\n<p>Source: Aviceda Therapeutics</p> </div></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aviceda Announces First Patient Enrolled in Phase 2 GLYCO Clinical Trial Evaluating AVD-104 for the Treatment of Diabetic Macular Edema</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAviceda Announces First Patient Enrolled in Phase 2 GLYCO Clinical Trial Evaluating AVD-104 for the Treatment of Diabetic Macular Edema\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-10 01:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=22613022><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AVD-104 is an engineered glycan (sialic acid) nanoparticle that reduces inflammation by targeting the self-pattern recognition receptors on overly activated retinal neutrophils, macrophages, and ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=22613022\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","LU1303367103.USD":"摩根大通多经理另类基金 A (acc)","LU1923623000.USD":"Natixis Thematics AI & Robotics Fund R/A USD","BK4585":"ETF&股票定投概念","LU1242518857.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"I\" (USD) ACC","LU2098885051.SGD":"JPMorgan Funds - Multi-Manager Alternatives A (acc) SGD","LU2458330169.SGD":"FRANKLIN SHARIAH TECHNOLOGY \"A\" (SGD) ACC","BK4575":"芯片概念","BK4566":"资本集团","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","LU2458330243.SGD":"FRANKLIN SHARIAH TECHNOLOGY \"A-H1\" (SGDHDG) ACC","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","IE00BMPRXR70.SGD":"Neuberger Berman 5G Connectivity A Acc SGD-H","LU0082616367.USD":"摩根大通美国科技A（dist）","LU0056508442.USD":"贝莱德世界科技基金A2","LU0719512351.SGD":"JPMorgan Funds - US Technology A (acc) SGD","BK4141":"半导体产品","BK4588":"碎股","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","AMD":"美国超微公司","IE00BMPRXN33.USD":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","BK4573":"虚拟现实","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","BK4512":"苹果概念","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","BK4093":"化肥与农用药剂","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","LU1852331112.SGD":"Blackrock World Technology Fund A2 SGD-H","AVD":"美国先锋","BK4529":"IDC概念","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU1951198990.SGD":"Natixis Thematics AI & Robotics Fund H-R/A SGD-H","BK4554":"元宇宙及AR概念","LU1951200564.SGD":"Natixis Thematics AI & Robotics Fund R/A SGD","BK4532":"文艺复兴科技持仓","IE0009356076.USD":"JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION \"A2\" (USD) ACC"},"source_url":"https://www.streetinsider.com/dr/news.php?id=22613022","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2402156309","content_text":"AVD-104 is an engineered glycan (sialic acid) nanoparticle that reduces inflammation by targeting the self-pattern recognition receptors on overly activated retinal neutrophils, macrophages, and microglia, and repolarizing them to their resolution state.\n\nAviceda is advancing the development of AVD-104, a Novel Glyco-Mimetic Nanoparticle, for the treatment of Diabetic Macular Edema as an indication expansion in addition to Geographic Atrophy (lead indication); AVD-104 is currently enrolling patients with GA in the SIGLEC Phase 2/3 Trial.\n\nA multi-center, multi-dose, open-label safety and tolerability study will enroll 30 patients to evaluate a low and high dose of AVD-104, with topline results expected in Q2 2024.\n\n CAMBRIDGE, Mass.--(BUSINESS WIRE)--\nAviceda Therapeutics, a private clinical-stage biotech company focused on developing next-generation immunomodulators by harnessing the power of glycobiology to alleviate chronic, non-resolving inflammation, announced today that they have enrolled the first patient in the GLYCO Phase 2 U.S. clinical trial evaluating their lead ophthalmic candidate AVD-104 for the management of diabetic macular edema (DME). AVD-104 is an engineered glycan (sialic acid) nanoparticle that reduces inflammation by targeting the self-pattern recognition receptors on overly activated retinal neutrophils, macrophages, and microglia, and repolarizing them to their resolution state.\n\nAshkan Abbey, M.D., of Texas Retina Associates said, “I am honored to dose AVD-104 in the first patient in the GLYCO trial to evaluate its potentially next-generation dual mechanism of action to reduce the chronic inflammation that drives many cases of DME.”\n\nMohamed Genead, M.D., Aviceda’s Co-founder and CEO said, “We are excited to evaluate the ability of AVD-104’s unique mechanism of action to provide DME patients with a safe treatment that may improve outcomes in eyes with DME driven by inflammatory and VEGF-mediated mechanisms.”\n\n“AVD-104 down-regulates neutrophils and has been shown to reduce the release of inflammatory cytokines,” explained David Callanan, M.D., Aviceda’s Chief Medical Officer and Senior Vice President. “There is still a need for improvement in the treatment of DME and we believe it may offer therapeutic advantages in the management of DME, and potentially in diabetic ischemia.”\n\nThe GLYCO Phase 2 U.S. clinical trial will evaluate the safety and treatment effects of intravitreal AVD-104 in patients with DME. This multi-center, open-label safety and tolerability study will enroll 30 patients to evaluate a low and high dose of AVD-104 with 3-month follow-up. The primary endpoint will be the incidence and severity of ocular and systemic adverse events. Secondary endpoint analyses will include standard evaluations of treatment efficacy, including macular thickness and vision. Further exploratory variables will include the potential effect of AVD-104 on macular ischemia.\n\nFurther information regarding the GLYCO trial can be found HERE.\n\nAbout Aviceda Therapeutics and AVD-104\n\nAviceda is a private, late-stage clinical biotechnology company located in Cambridge, MA, with a proprietary HALOS™ nanotechnology platform and a clinical stage ophthalmic candidate, AVD-104, for the treatment of geographic atrophy secondary to age-related macular degeneration (AMD) and diabetic macular edema. AVD-104 is a promising intravitreal glycan-coated nanoparticle with a dual mechanism of action that modulates critical inflammatory cellular and complement pathways through 1) direct inhibition of the activity of damaging neutrophils and phagocytic macrophages and repolarization of activated macrophages to their resolution state and 2) inhibition of complement cascade amplification. AVD-104 has completed dosing in the single ascending dose Part I of the company’s Phase 2/3 SIGLEC trial, which is evaluating patients with geographic atrophy secondary to AMD. Topline three-month data from Part I is expected in early 2024 along with the initiation of Part II, which is a double-masked, randomized, active comparator trial. Part II of the Phase 2/3 trial will enroll 300 patients across U.S. clinical sites.\n\nAlong with AVD-104, Aviceda has a broad pipeline of products in development in ophthalmology and multiple other therapeutic areas, including oncology, immunology, neurology, and fibrosis.\n\nLearn more about Aviceda Therapeutics.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20240109176126/en/\n\nOrganization Contact:\nAviceda Therapeutics Inc.\n[email protected]\n\nSource: Aviceda Therapeutics","news_type":1},"isVote":1,"tweetType":1,"viewCount":731,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":221185427062792,"gmtCreate":1695040073723,"gmtModify":1695043301900,"author":{"id":"3547492843908436","authorId":"3547492843908436","name":"Alicent","avatar":"https://static.tigerbbs.com/0a7b09bfad47e4ab0b7a96cdfaec4d6d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3547492843908436","idStr":"3547492843908436"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RDHL\">$Redhill Biopharma Ltd(RDHL)$&nbsp;</a>老虎证券里的资讯没有 Yahoo Finance 里的股票新闻及时。 这支股票今天获得美国 FDA 批准用于治疗幽门螺旋杆菌的简化用药方案","listText":"<a href=\"https://laohu8.com/S/RDHL\">$Redhill Biopharma Ltd(RDHL)$&nbsp;</a>老虎证券里的资讯没有 Yahoo Finance 里的股票新闻及时。 这支股票今天获得美国 FDA 批准用于治疗幽门螺旋杆菌的简化用药方案","text":"$Redhill Biopharma Ltd(RDHL)$ 老虎证券里的资讯没有 Yahoo Finance 里的股票新闻及时。 这支股票今天获得美国 FDA 批准用于治疗幽门螺旋杆菌的简化用药方案","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/221185427062792","isVote":1,"tweetType":1,"viewCount":1544,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":397129681,"gmtCreate":1608211177443,"gmtModify":1703851787936,"author":{"id":"3547492843908436","authorId":"3547492843908436","name":"Alicent","avatar":"https://static.tigerbbs.com/0a7b09bfad47e4ab0b7a96cdfaec4d6d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3547492843908436","idStr":"3547492843908436"},"themes":[],"htmlText":"截图里的行情如何能看到？如何能看到粉票市场的盘前盘后？","listText":"截图里的行情如何能看到？如何能看到粉票市场的盘前盘后？","text":"截图里的行情如何能看到？如何能看到粉票市场的盘前盘后？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/397129681","repostId":"1113876805","repostType":4,"repost":{"id":"1113876805","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1608210883,"share":"https://www.laohu8.com/m/news/1113876805?lang=&edition=full","pubTime":"2020-12-17 21:14","market":"us","language":"zh","title":"瑞幸咖啡盘前大涨44%，1.8亿美元与SEC达成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=1113876805","media":"老虎资讯综合","summary":"12月17日，$瑞幸咖啡(LK)$在美国粉单市场盘前大涨44%。老虎综合账户可以交易在粉单市场的瑞幸咖啡股票。\n\n\n\n美国证券交易委员会（SEC）发布消息称，与$瑞幸咖啡(LK)$达成和解，后者同意针对造假指控支付1.8亿美元（约合人民币11.8亿元）罚款。\n\nSEC表示，从2019年4月至2020年1月，瑞幸通过关联方虚假交易伪造了超过3亿美元的销售额，从债券和股票投资者那里筹集了超过8.64亿美元资金。不过，这项和解协议需要得到法院的同意才能生效。\n\n截至目前，瑞幸面临的各项处罚总金额超过12亿元人民币。","content":"<p>12月17日，<a href=\"https://laohu8.com/S/LK\">瑞幸咖啡</a>在美国粉单市场盘前大涨44%。<b>老虎综合账户可以交易在粉单市场的瑞幸咖啡股票。</b></p><p><img src=\"https://static.tigerbbs.com/bfe41adbad20b5a5d4260d2efba48813\" tg-width=\"369\" tg-height=\"800\"></p><p>美国证券交易委员会（SEC）发布消息称，与<a href=\"https://laohu8.com/S/LK\">瑞幸咖啡</a>达成和解，后者同意针对造假指控支付1.8亿美元（约合人民币11.8亿元）罚款。</p><p>SEC表示，从2019年4月至2020年1月，瑞幸通过关联方虚假交易伪造了超过3亿美元的销售额，从债券和股票投资者那里筹集了超过8.64亿美元资金。不过，这项和解协议需要得到法院的同意才能生效。</p><p>截至目前，瑞幸面临的各项处罚总金额超过12亿元人民币。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>瑞幸咖啡盘前大涨44%，1.8亿美元与SEC达成和解</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n瑞幸咖啡盘前大涨44%，1.8亿美元与SEC达成和解\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-12-17 21:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>12月17日，<a href=\"https://laohu8.com/S/LK\">瑞幸咖啡</a>在美国粉单市场盘前大涨44%。<b>老虎综合账户可以交易在粉单市场的瑞幸咖啡股票。</b></p><p><img src=\"https://static.tigerbbs.com/bfe41adbad20b5a5d4260d2efba48813\" tg-width=\"369\" tg-height=\"800\"></p><p>美国证券交易委员会（SEC）发布消息称，与<a href=\"https://laohu8.com/S/LK\">瑞幸咖啡</a>达成和解，后者同意针对造假指控支付1.8亿美元（约合人民币11.8亿元）罚款。</p><p>SEC表示，从2019年4月至2020年1月，瑞幸通过关联方虚假交易伪造了超过3亿美元的销售额，从债券和股票投资者那里筹集了超过8.64亿美元资金。不过，这项和解协议需要得到法院的同意才能生效。</p><p>截至目前，瑞幸面临的各项处罚总金额超过12亿元人民币。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/3d12f820102df1859c1d25e4011ee104","relate_stocks":{"LKNCY":"瑞幸咖啡"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113876805","content_text":"12月17日，瑞幸咖啡在美国粉单市场盘前大涨44%。老虎综合账户可以交易在粉单市场的瑞幸咖啡股票。美国证券交易委员会（SEC）发布消息称，与瑞幸咖啡达成和解，后者同意针对造假指控支付1.8亿美元（约合人民币11.8亿元）罚款。SEC表示，从2019年4月至2020年1月，瑞幸通过关联方虚假交易伪造了超过3亿美元的销售额，从债券和股票投资者那里筹集了超过8.64亿美元资金。不过，这项和解协议需要得到法院的同意才能生效。截至目前，瑞幸面临的各项处罚总金额超过12亿元人民币。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":303051057,"gmtCreate":1602834934679,"gmtModify":1703828107110,"author":{"id":"3547492843908436","authorId":"3547492843908436","name":"Alicent","avatar":"https://static.tigerbbs.com/0a7b09bfad47e4ab0b7a96cdfaec4d6d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3547492843908436","idStr":"3547492843908436"},"themes":[],"htmlText":"说苹果创新缺失的恐怕是准备抄底的吧","listText":"说苹果创新缺失的恐怕是准备抄底的吧","text":"说苹果创新缺失的恐怕是准备抄底的吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/303051057","repostId":"2075034139","repostType":2,"isVote":1,"tweetType":1,"viewCount":1899,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":300815169,"gmtCreate":1602129625451,"gmtModify":1703825902705,"author":{"id":"3547492843908436","authorId":"3547492843908436","name":"Alicent","avatar":"https://static.tigerbbs.com/0a7b09bfad47e4ab0b7a96cdfaec4d6d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3547492843908436","idStr":"3547492843908436"},"themes":[],"htmlText":"逗死了","listText":"逗死了","text":"逗死了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/300815169","repostId":"1183475784","repostType":4,"isVote":1,"tweetType":1,"viewCount":2658,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3527667803686145","idStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":300815169,"gmtCreate":1602129625451,"gmtModify":1703825902705,"author":{"id":"3547492843908436","authorId":"3547492843908436","name":"Alicent","avatar":"https://static.tigerbbs.com/0a7b09bfad47e4ab0b7a96cdfaec4d6d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547492843908436","authorIdStr":"3547492843908436"},"themes":[],"htmlText":"逗死了","listText":"逗死了","text":"逗死了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/300815169","repostId":"1183475784","repostType":4,"repost":{"id":"1183475784","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1602127718,"share":"https://www.laohu8.com/m/news/1183475784?lang=&edition=full","pubTime":"2020-10-08 11:28","market":"us","language":"zh","title":"美国副总统候选人电视辩论结束，特朗普发推：彭斯大赢！","url":"https://stock-news.laohu8.com/highlight/detail?id=1183475784","media":"老虎资讯综合","summary":"美东时间10月7日晚9时许，美国副总统彭斯和民主党副总统候选人卡玛拉·哈里斯在盐湖城犹他大学举行首场、也是唯一一场副总统候选人电视辩论。辩论由《今日美国》华盛顿分社社长苏珊·佩奇主持。整个辩论围绕新冠","content":"<p>美东时间10月7日晚9时许，美国副总统彭斯和民主党副总统候选人卡玛拉·哈里斯在盐湖城犹他大学举行首场、也是唯一一场副总统候选人电视辩论。辩论由《今日美国》华盛顿分社社长苏珊·佩奇主持。整个辩论围绕新冠疫情、医疗保健、经济、气候变化和外交政策等多个话题展开。</p><p><img src=\"https://static.tigerbbs.com/62a4c2e6bd440b7dfd28a9a6671a1a53\" tg-width=\"640\" tg-height=\"225\"></p><p>就在刚刚，在彭斯和哈里斯的辩论结束后不久，美国总统特朗普发推称，“迈克·彭斯大赢！”</p><p><b>美国大选今日看点：“蛰伏”的哈里斯单挑“特朗普的病毒防火墙”彭斯</b></p><p>1.“蛰伏”的哈里斯</p><p>自从成为拜登竞选伙伴后，这位加利福尼亚州参议员在很大程度上一直处于保密状态，这让她的支持者感到沮丧。一向以锋芒著称的哈里斯，在走上人生最高舞台后，为什么反而“蛰伏”了？</p><p>周三和彭斯的辩论之夜，会是她在大选期间唯一光彩夺目的时刻吗？</p><p>十年前哈里斯当选加州总检察长几年后的一天，哈里斯与几名助手坐在旧金山，有人猜测她有朝一日会成为总统。</p><p>房间里顿时安静下来，半数的工作人员转向这位民主党新秀，想看看她会有什么反应。大家在讨论哈里斯将在国家舞台上扮演更大的角色。</p><p>哈里斯说：“我永远不会想当总统。”</p><p>据在场的一位人士回忆，她把这个国家的最高职位斥为 “可怕的工作”。</p><p>然后，哈里斯以无可挑剔的时机，说出了笑点。</p><p>短暂地停顿了一下，她说，“现在，副总统？这听起来并不那么糟糕。”</p><p><img src=\"https://static.tigerbbs.com/ad30478e6d046d997aeb6ef5a8809da2\" tg-width=\"640\" tg-height=\"426\"></p><p>去年，哈里斯曾经宣布参选总统，之后又退出初选，竞选成为二号人物成为非常适合哈里斯的选择。</p><p>10月7日本周三晚上，她将与副总统迈克·彭斯（Mike Pence）对决，这或许是她竞选中最重要的时刻。</p><p>乔·拜登选择哈里斯让民主党人兴奋不已。她帮助他以创纪录的速度筹集资金。她是拜登在密尔沃基、底特律和费城等摇摆州城市最高调的代理人，帮助他争取有色人种选民，包括非洲裔美国人和拉丁裔美国人。</p><p>哈里斯单独或与拜登一起出现在电视广告中，这对副总统竞选人来说是罕见的。她在竞选活动推出的数字视频中担任明星，她已经成为77岁的拜登的流行文化使者，她与音乐偶像一起出现，参加面向非政治受众的播客，她穿着匡威Chuck Taylor运动鞋走下飞机的简短视频吸引了数百万人的观看。</p><p><b>最不引人注目的副总统候选人</b></p><p>不过，根据到目前为止的情况，拜登的避开聚光灯的竞选策略加上冠状病毒，已经使哈里斯成为最近记忆中最不引人注目的副总统竞选人。这让一些粉丝和盟友感到沮丧，他们希望选民看到更多的她，并认为这将有助于选票。</p><p><img src=\"https://static.tigerbbs.com/1996dee67c20cbec077a3b66460a3bdf\" tg-width=\"640\" tg-height=\"426\"></p><p>当她走访餐馆、花店和理发店时，这些活动仅限于当地记者和旅行的记者，他们必须乘坐商业航班才能赶上这位副总统候选人。</p><p>她的低调是二号人物的固有形象。而且可以肯定的是，她并不是唯一低调的人。拜登本人也保持着有限的公开日程，部分原因是冠状病毒，同时也因为，他希望选民针对特朗普的表现做出判断，而不是自己在竞选中的行为。</p><p>伊利诺伊州库克县的州检察官金·福克斯说：“我知道有关副总统人选的传统想法是，你想要一个能让人们激动的人，一个不会造成伤害的人。我认为参议员哈里斯已经证明了，她不是那种你必须担心的人。当然我希望，在竞选的最后几天，他们能最大限度地发挥哈里斯的最大优势。”</p><p><b>哈里斯最大的机会来自犹他州以及与副总统彭斯的辩论。</b></p><p>长期以来，哈里斯的助手们一直把这场辩论视为展示她犀利风格的最大舞台。特朗普带着病毒在医院度过周末后重返白宫，这对于她是一个好消息。</p><p>助手们说，她原计划把他的履历作为攻击的重点，由于总统宣称他的状况有所改善，那么进行这些攻击的时候可以毫不留情了。</p><p><img src=\"https://static.tigerbbs.com/bbc722a0c9d1e0aa2c83ec8e5aa10fc6\" tg-width=\"640\" tg-height=\"426\"></p><p>一位接近竞选团队的人士表示：“她可以对特朗普强硬，而不用担心（他的身体状况），我相信她会把彭斯当作起诉唐纳德·特朗普的证人。”</p><p>本月晚些时候，在特朗普提名的最高法院大法官艾米·科尼·巴雷特(Amy Coney Barrett)的参议院听证会上，她可能会再次成为公众关注的焦点。哈里斯是司法委员会的成员，她对巴雷特的质询是听证会中最受期待的时刻。</p><p>大家对哈里斯的渴望表明她在这几个月里取得了多大的进步。去年年底她退出初选时，她的支持率在30 - 35左右徘徊。在拜登选她做副总统之前，她为自己的政治回归奠定了基调。今年夏天，哈里斯卷土重来，成为支持华盛顿警察改革的最知名政治家之一。</p><p>尽管她是副总统这个职位的早期领先者，一些拜登的盟友和她家乡州的民主党人警告竞选团队说，她将很难成为一个团队成员。</p><p>哈里斯一直在努力克服这些看法，而拜登的竞选团队也在努力消除围绕这位候选人的任何戏剧性迹象。</p><p><img src=\"https://static.tigerbbs.com/9f0884349c204f0a83685db23fedcac4\" tg-width=\"640\" tg-height=\"426\"></p><p>重返竞选活动后，哈里斯对谈论自己的角色非常谨慎，甚至在私人谈话中也是如此。但在她的行程开始安排之前，她向朋友和捐款人分享了她对这次比初选更轻松的行程安排的看法，表示松了一口气，并表示这给了她更多的时间来准备。</p><p><b>低调中，支持率一路攀升</b></p><p>最近几周，她的平均支持率攀升至45%左右，美国有线电视新闻网CNN周二公布的民调显示，支持率最高达到50%。</p><p>尽管哈里斯在很大程度上避免了她在竞选活动中面临的审视，尤其是围绕她自己的履历，但她也没有完全避免这些小插曲。她因优先接受当地采访和非政治媒体的提问而受到批评。</p><p>她拒绝在大选前表示是否会接受已获批准的冠状病毒疫苗，以表明她对特朗普的不信任，以及需要卫生专家的保证。这让她的竞选遭到了批评，有人称她反对针对该病毒的潜在治疗方法。</p><p>哈里斯接受美国有线电视新闻网CNN采访，当她被问及是否会在选举前接种疫苗时说：“嗯，我认为这将是我们所有人面临的一个问题。”</p><p><img src=\"https://static.tigerbbs.com/4291776cd49acef0945bb2f80202c39e\" tg-width=\"640\" tg-height=\"427\"></p><p>在另一次交流中，哈里斯被她和拜登宣布支持全国戴口罩后出现的问题搞得不知所措。拜登后来又说，总统授权使用口罩的权限尚不清楚，他自己也使用了“标准”的含糊语言。</p><p>而在被问及扩大最高法院时，哈里斯含糊其辞，此前她对这个想法持开放态度。拜登说，在初选期间，他反对增加最高法院的大法官，但现在拒绝对此作出回答，他说，他说的任何话都会分散注意力。</p><p>总而言之，从各方面来看，从她成为拜登副手的热门人选到目前为止，哈里斯已经成功地消除了反对者的担忧：她将使拜登黯然失色。</p><p>一位竞选活动的捐助者说：“拜登是领导者，她正在强化这个信息。”</p><p><b>严格执行竞选剧本</b></p><p>哈里斯在初选中遇到了麻烦，她偏离了剧本——或者说根本没有剧本。</p><p>早在2018年，当她在一次市政厅会议上被问及是否会拒绝企业或者企业游说者的捐款时，她说“这不一定”，然后她在仅仅几周后就改变了方向，选择不接受企业的钱。在初选期间，她竭力表达自己到底打算如何解决医保问题，而拜登竞选团队却驳斥了她提出的“万能”方案。</p><p><img src=\"https://static.tigerbbs.com/741e011db0d9013e9d366629f379aac4\" tg-width=\"640\" tg-height=\"427\"></p><p>但现在哈里斯的计划就是拜登的计划。而正如哈里斯在国会听证会上的表现所证明的那样，当她准备好了的时候，她可以是毁灭性的。</p><p>上周，当特朗普住院时，哈里斯似乎不得不缓和她对总统的尖锐批评，这是一个微妙的任务。但现在，特朗普回到了白宫，而且开始在推特上怒发冲冠，没有人会指望哈里斯针对总统的态度会软下来。</p><p>今晚是哈里斯上演的第一幕。她将在本月晚些时候的参议院听证会上对最高法院提名人艾米·科尼·巴雷特的预期质询中扮演第二个更重要的角色。</p><p>2.成为防火墙的彭斯</p><p>美国副总统迈克·彭斯今晚有政界最艰难的工作：为特朗普政府针对疫情施行的对策作辩护。</p><p><img src=\"https://static.tigerbbs.com/7f84cc0221441f5b1cd3bcfc825aadbd\" tg-width=\"640\" tg-height=\"426\"></p><p>彭斯有很多事例材料可以使用。新冠病毒大流行来势汹汹，总统自己也被感染，直到本周一才离开医院。白宫已经成为感染的热点。如果这些麻烦事情还不够，特朗普本周二取消了与众议院议长南希·佩洛西关于疫情救济方案的谈判，这一举动使得金融市场在他特朗普从医院回来的第一天就遭到打击。</p><p>特朗普今晚需要从彭斯那里得到的是他一直需要的东西——对共和党人和右倾独立人士进行冷静和理性的解释，即无论情况多么混乱，他们所关心的保守派政策和最高法院提名人也都会和特朗普-彭斯的入场券一同出现。</p><p>彭斯其实之前就做过这项工作。2016年，就在彭斯与蒂姆·凯恩辩论之前，特朗普威胁要起诉《纽约时报》，因为该报报道他逃避纳税(由于最近的报道，逃税这个话题很可能在今晚再次出现)。而特朗普在当时有最大的热点事件让彭斯来转移话题，话题内容包括从黑客主义到特朗普关于移民的言论。（注：蒂姆·凯恩现任美国参议员，是2016年民主党副总统的参选人。）</p><p><b>彭斯的优势是，他领导了特朗普政府的新冠病毒专案组</b>。</p><p>目前已经有超过20万美国人死于新冠病毒，美国全国大部分地区也已经关闭封锁了几个月。彭斯领导的特朗普政府新冠病毒工作组的角色，使他成为舆论批评攻击政府应对此次疫情的主要目标。</p><p><img src=\"https://static.tigerbbs.com/2beabb2710c1f30a27bb5574a0824975\" tg-width=\"640\" tg-height=\"426\"></p><p>哈里斯将因白宫停滞不前、时而混乱的情况而抨击彭斯，并且舆论的力量是站在她这一边的。</p><p>彭斯在这里没有什么好的选择。他可以指出特朗普感染病毒作为证据，证明病毒是可以战胜的，但是特朗普的病情细节仍然模糊不清，而且特朗普可以获得大多数美国人梦寐以求也得不到的医疗护理水平。他也可以责怪中国，说明情况可能会更糟。他还可以主张开放企业和学校，以减少疫情造成的长期的经济损失。</p><p>但即使是彭斯最有效的手段——把话题转到其他地方，这次也很难执行，因为病毒是人们首要考虑的问题。盐湖城的情况非常严峻，以至于今天早上当地报纸关于辩论的报道占据了报纸头条，同时还有关于市长敦促恢复某些公共卫生限制的事情。</p><p><b>展望2024年</b></p><p>历史表明，今晚的副总统辩论几乎肯定不会影响这次选举的结果。但它可能会是下一次总统选举的预演。</p><p>无论拜登还是特朗普获胜，哈里斯很可能会在下一次开放的民主党总统初选中成为领跑者，无论是2024年还是2028年。</p><p>而彭斯呢？客气地说，他很稳定，虽然有时很无聊。但谁也不知道四年或者八年的特朗普政府之后，共和党人的性情会有什么变化。彭斯在共和党人中的支持率很稳固，他在基督教保守派中也得到一些支持。</p><p><img src=\"https://static.tigerbbs.com/804fc160873d5937d26f011ba169b9d9\" tg-width=\"640\" tg-height=\"426\"></p><p>彭斯的未来前景与特朗普密不可分，他的政治立场是十足的MAGA。但他也一直小心翼翼地与总统进行一些区分，而且今晚他很可能要再次这样做。（注：MAGA即“让美国再次伟大” (Make America Great Again)。这个竞选口号第一次是在1980年美国总统选举中被共和党总统候选人罗纳德·里根使用。后来2016年美国总统选举，又被共和党总统候选人特朗普使用。）</p><p>我们可以看看彭斯今年夏天在共和党全国代表大会上言论的重现，当时他说，特朗普“以自己的方式，按照自己的条件做事”。当彭斯说“有些人认为我们有点不同”时，这并不是在挖苦总统。但这也是彭斯在四年后能够回过头来指出的话，至少是作为某种分离的证据。</p><p><b>美国最高法院重设</b></p><p>特朗普的住院以及他周围共和党人的感染，这些事情把对巴雷特提名的关注转成了对白宫新冠病毒事件的研究。</p><p>如果彭斯今晚可以为特朗普做任何事情，那将是重新设置最高法院听证会作为竞选活动的焦点。共和党人认为，突出巴雷特可以为基础选民注入活力，并说服倾向保守的独立人士摆脱对特朗普性情或其他方面工作表现的保留意见。</p><p><img src=\"https://static.tigerbbs.com/2819781bbbacd68514bef338d989ff19\" tg-width=\"640\" tg-height=\"426\"></p><p>摆在眼前的是最高法院将在选举日一周后审理的一个削弱平价医疗法案的案件。</p><p>哈里斯将有机会打击彭斯关于政府取消医疗保健保护的做法。彭斯表示，他希望这项具有里程碑意义的裁决能够被推翻。</p><p>而彭斯也将获得一个机会，他可以就扩大最高法院的问题向哈里斯施压，因为她此前曾表示对这一问题持开放态度，但拜登拒绝解决这一问题。</p><p><b>生存和死亡是一个阶段</b></p><p>哈里斯已经赢得了第一轮辩论，尽管它甚至还没有开始。在辩论现场，有机玻璃将分隔开两位候选人，这清楚地提醒了公众特朗普政府无力控制新冠病毒大流行，甚至在白宫内部都没能控制。</p><p><img src=\"https://static.tigerbbs.com/4e0ddb0b609f120a1ac7d5c14a56f954\" tg-width=\"640\" tg-height=\"426\"></p><p>彭斯曾反对这样的设置，这是一个严重的误判。当然，对他来说，更好的结果是不竖立这种防止病毒传播的物理隔断。但在抵制（然后屈服）后他将付出双重代价——哈里斯不仅得到有机玻璃，而且还可以逼问彭斯为什么他反对这样的措施。</p><p>这并不是特朗普-彭斯选举团队想要进行的对话。而如果彭斯无法阻止组织者采取更严格的公共卫生措施，那么很难看到刚刚带着病毒离开医院的特朗普接下来在辩论中将如何做得更好。辩论组织者承诺表示将更加严格地执行戴口罩的规定。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美国副总统候选人电视辩论结束，特朗普发推：彭斯大赢！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美国副总统候选人电视辩论结束，特朗普发推：彭斯大赢！\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-10-08 11:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>美东时间10月7日晚9时许，美国副总统彭斯和民主党副总统候选人卡玛拉·哈里斯在盐湖城犹他大学举行首场、也是唯一一场副总统候选人电视辩论。辩论由《今日美国》华盛顿分社社长苏珊·佩奇主持。整个辩论围绕新冠疫情、医疗保健、经济、气候变化和外交政策等多个话题展开。</p><p><img src=\"https://static.tigerbbs.com/62a4c2e6bd440b7dfd28a9a6671a1a53\" tg-width=\"640\" tg-height=\"225\"></p><p>就在刚刚，在彭斯和哈里斯的辩论结束后不久，美国总统特朗普发推称，“迈克·彭斯大赢！”</p><p><b>美国大选今日看点：“蛰伏”的哈里斯单挑“特朗普的病毒防火墙”彭斯</b></p><p>1.“蛰伏”的哈里斯</p><p>自从成为拜登竞选伙伴后，这位加利福尼亚州参议员在很大程度上一直处于保密状态，这让她的支持者感到沮丧。一向以锋芒著称的哈里斯，在走上人生最高舞台后，为什么反而“蛰伏”了？</p><p>周三和彭斯的辩论之夜，会是她在大选期间唯一光彩夺目的时刻吗？</p><p>十年前哈里斯当选加州总检察长几年后的一天，哈里斯与几名助手坐在旧金山，有人猜测她有朝一日会成为总统。</p><p>房间里顿时安静下来，半数的工作人员转向这位民主党新秀，想看看她会有什么反应。大家在讨论哈里斯将在国家舞台上扮演更大的角色。</p><p>哈里斯说：“我永远不会想当总统。”</p><p>据在场的一位人士回忆，她把这个国家的最高职位斥为 “可怕的工作”。</p><p>然后，哈里斯以无可挑剔的时机，说出了笑点。</p><p>短暂地停顿了一下，她说，“现在，副总统？这听起来并不那么糟糕。”</p><p><img src=\"https://static.tigerbbs.com/ad30478e6d046d997aeb6ef5a8809da2\" tg-width=\"640\" tg-height=\"426\"></p><p>去年，哈里斯曾经宣布参选总统，之后又退出初选，竞选成为二号人物成为非常适合哈里斯的选择。</p><p>10月7日本周三晚上，她将与副总统迈克·彭斯（Mike Pence）对决，这或许是她竞选中最重要的时刻。</p><p>乔·拜登选择哈里斯让民主党人兴奋不已。她帮助他以创纪录的速度筹集资金。她是拜登在密尔沃基、底特律和费城等摇摆州城市最高调的代理人，帮助他争取有色人种选民，包括非洲裔美国人和拉丁裔美国人。</p><p>哈里斯单独或与拜登一起出现在电视广告中，这对副总统竞选人来说是罕见的。她在竞选活动推出的数字视频中担任明星，她已经成为77岁的拜登的流行文化使者，她与音乐偶像一起出现，参加面向非政治受众的播客，她穿着匡威Chuck Taylor运动鞋走下飞机的简短视频吸引了数百万人的观看。</p><p><b>最不引人注目的副总统候选人</b></p><p>不过，根据到目前为止的情况，拜登的避开聚光灯的竞选策略加上冠状病毒，已经使哈里斯成为最近记忆中最不引人注目的副总统竞选人。这让一些粉丝和盟友感到沮丧，他们希望选民看到更多的她，并认为这将有助于选票。</p><p><img src=\"https://static.tigerbbs.com/1996dee67c20cbec077a3b66460a3bdf\" tg-width=\"640\" tg-height=\"426\"></p><p>当她走访餐馆、花店和理发店时，这些活动仅限于当地记者和旅行的记者，他们必须乘坐商业航班才能赶上这位副总统候选人。</p><p>她的低调是二号人物的固有形象。而且可以肯定的是，她并不是唯一低调的人。拜登本人也保持着有限的公开日程，部分原因是冠状病毒，同时也因为，他希望选民针对特朗普的表现做出判断，而不是自己在竞选中的行为。</p><p>伊利诺伊州库克县的州检察官金·福克斯说：“我知道有关副总统人选的传统想法是，你想要一个能让人们激动的人，一个不会造成伤害的人。我认为参议员哈里斯已经证明了，她不是那种你必须担心的人。当然我希望，在竞选的最后几天，他们能最大限度地发挥哈里斯的最大优势。”</p><p><b>哈里斯最大的机会来自犹他州以及与副总统彭斯的辩论。</b></p><p>长期以来，哈里斯的助手们一直把这场辩论视为展示她犀利风格的最大舞台。特朗普带着病毒在医院度过周末后重返白宫，这对于她是一个好消息。</p><p>助手们说，她原计划把他的履历作为攻击的重点，由于总统宣称他的状况有所改善，那么进行这些攻击的时候可以毫不留情了。</p><p><img src=\"https://static.tigerbbs.com/bbc722a0c9d1e0aa2c83ec8e5aa10fc6\" tg-width=\"640\" tg-height=\"426\"></p><p>一位接近竞选团队的人士表示：“她可以对特朗普强硬，而不用担心（他的身体状况），我相信她会把彭斯当作起诉唐纳德·特朗普的证人。”</p><p>本月晚些时候，在特朗普提名的最高法院大法官艾米·科尼·巴雷特(Amy Coney Barrett)的参议院听证会上，她可能会再次成为公众关注的焦点。哈里斯是司法委员会的成员，她对巴雷特的质询是听证会中最受期待的时刻。</p><p>大家对哈里斯的渴望表明她在这几个月里取得了多大的进步。去年年底她退出初选时，她的支持率在30 - 35左右徘徊。在拜登选她做副总统之前，她为自己的政治回归奠定了基调。今年夏天，哈里斯卷土重来，成为支持华盛顿警察改革的最知名政治家之一。</p><p>尽管她是副总统这个职位的早期领先者，一些拜登的盟友和她家乡州的民主党人警告竞选团队说，她将很难成为一个团队成员。</p><p>哈里斯一直在努力克服这些看法，而拜登的竞选团队也在努力消除围绕这位候选人的任何戏剧性迹象。</p><p><img src=\"https://static.tigerbbs.com/9f0884349c204f0a83685db23fedcac4\" tg-width=\"640\" tg-height=\"426\"></p><p>重返竞选活动后，哈里斯对谈论自己的角色非常谨慎，甚至在私人谈话中也是如此。但在她的行程开始安排之前，她向朋友和捐款人分享了她对这次比初选更轻松的行程安排的看法，表示松了一口气，并表示这给了她更多的时间来准备。</p><p><b>低调中，支持率一路攀升</b></p><p>最近几周，她的平均支持率攀升至45%左右，美国有线电视新闻网CNN周二公布的民调显示，支持率最高达到50%。</p><p>尽管哈里斯在很大程度上避免了她在竞选活动中面临的审视，尤其是围绕她自己的履历，但她也没有完全避免这些小插曲。她因优先接受当地采访和非政治媒体的提问而受到批评。</p><p>她拒绝在大选前表示是否会接受已获批准的冠状病毒疫苗，以表明她对特朗普的不信任，以及需要卫生专家的保证。这让她的竞选遭到了批评，有人称她反对针对该病毒的潜在治疗方法。</p><p>哈里斯接受美国有线电视新闻网CNN采访，当她被问及是否会在选举前接种疫苗时说：“嗯，我认为这将是我们所有人面临的一个问题。”</p><p><img src=\"https://static.tigerbbs.com/4291776cd49acef0945bb2f80202c39e\" tg-width=\"640\" tg-height=\"427\"></p><p>在另一次交流中，哈里斯被她和拜登宣布支持全国戴口罩后出现的问题搞得不知所措。拜登后来又说，总统授权使用口罩的权限尚不清楚，他自己也使用了“标准”的含糊语言。</p><p>而在被问及扩大最高法院时，哈里斯含糊其辞，此前她对这个想法持开放态度。拜登说，在初选期间，他反对增加最高法院的大法官，但现在拒绝对此作出回答，他说，他说的任何话都会分散注意力。</p><p>总而言之，从各方面来看，从她成为拜登副手的热门人选到目前为止，哈里斯已经成功地消除了反对者的担忧：她将使拜登黯然失色。</p><p>一位竞选活动的捐助者说：“拜登是领导者，她正在强化这个信息。”</p><p><b>严格执行竞选剧本</b></p><p>哈里斯在初选中遇到了麻烦，她偏离了剧本——或者说根本没有剧本。</p><p>早在2018年，当她在一次市政厅会议上被问及是否会拒绝企业或者企业游说者的捐款时，她说“这不一定”，然后她在仅仅几周后就改变了方向，选择不接受企业的钱。在初选期间，她竭力表达自己到底打算如何解决医保问题，而拜登竞选团队却驳斥了她提出的“万能”方案。</p><p><img src=\"https://static.tigerbbs.com/741e011db0d9013e9d366629f379aac4\" tg-width=\"640\" tg-height=\"427\"></p><p>但现在哈里斯的计划就是拜登的计划。而正如哈里斯在国会听证会上的表现所证明的那样，当她准备好了的时候，她可以是毁灭性的。</p><p>上周，当特朗普住院时，哈里斯似乎不得不缓和她对总统的尖锐批评，这是一个微妙的任务。但现在，特朗普回到了白宫，而且开始在推特上怒发冲冠，没有人会指望哈里斯针对总统的态度会软下来。</p><p>今晚是哈里斯上演的第一幕。她将在本月晚些时候的参议院听证会上对最高法院提名人艾米·科尼·巴雷特的预期质询中扮演第二个更重要的角色。</p><p>2.成为防火墙的彭斯</p><p>美国副总统迈克·彭斯今晚有政界最艰难的工作：为特朗普政府针对疫情施行的对策作辩护。</p><p><img src=\"https://static.tigerbbs.com/7f84cc0221441f5b1cd3bcfc825aadbd\" tg-width=\"640\" tg-height=\"426\"></p><p>彭斯有很多事例材料可以使用。新冠病毒大流行来势汹汹，总统自己也被感染，直到本周一才离开医院。白宫已经成为感染的热点。如果这些麻烦事情还不够，特朗普本周二取消了与众议院议长南希·佩洛西关于疫情救济方案的谈判，这一举动使得金融市场在他特朗普从医院回来的第一天就遭到打击。</p><p>特朗普今晚需要从彭斯那里得到的是他一直需要的东西——对共和党人和右倾独立人士进行冷静和理性的解释，即无论情况多么混乱，他们所关心的保守派政策和最高法院提名人也都会和特朗普-彭斯的入场券一同出现。</p><p>彭斯其实之前就做过这项工作。2016年，就在彭斯与蒂姆·凯恩辩论之前，特朗普威胁要起诉《纽约时报》，因为该报报道他逃避纳税(由于最近的报道，逃税这个话题很可能在今晚再次出现)。而特朗普在当时有最大的热点事件让彭斯来转移话题，话题内容包括从黑客主义到特朗普关于移民的言论。（注：蒂姆·凯恩现任美国参议员，是2016年民主党副总统的参选人。）</p><p><b>彭斯的优势是，他领导了特朗普政府的新冠病毒专案组</b>。</p><p>目前已经有超过20万美国人死于新冠病毒，美国全国大部分地区也已经关闭封锁了几个月。彭斯领导的特朗普政府新冠病毒工作组的角色，使他成为舆论批评攻击政府应对此次疫情的主要目标。</p><p><img src=\"https://static.tigerbbs.com/2beabb2710c1f30a27bb5574a0824975\" tg-width=\"640\" tg-height=\"426\"></p><p>哈里斯将因白宫停滞不前、时而混乱的情况而抨击彭斯，并且舆论的力量是站在她这一边的。</p><p>彭斯在这里没有什么好的选择。他可以指出特朗普感染病毒作为证据，证明病毒是可以战胜的，但是特朗普的病情细节仍然模糊不清，而且特朗普可以获得大多数美国人梦寐以求也得不到的医疗护理水平。他也可以责怪中国，说明情况可能会更糟。他还可以主张开放企业和学校，以减少疫情造成的长期的经济损失。</p><p>但即使是彭斯最有效的手段——把话题转到其他地方，这次也很难执行，因为病毒是人们首要考虑的问题。盐湖城的情况非常严峻，以至于今天早上当地报纸关于辩论的报道占据了报纸头条，同时还有关于市长敦促恢复某些公共卫生限制的事情。</p><p><b>展望2024年</b></p><p>历史表明，今晚的副总统辩论几乎肯定不会影响这次选举的结果。但它可能会是下一次总统选举的预演。</p><p>无论拜登还是特朗普获胜，哈里斯很可能会在下一次开放的民主党总统初选中成为领跑者，无论是2024年还是2028年。</p><p>而彭斯呢？客气地说，他很稳定，虽然有时很无聊。但谁也不知道四年或者八年的特朗普政府之后，共和党人的性情会有什么变化。彭斯在共和党人中的支持率很稳固，他在基督教保守派中也得到一些支持。</p><p><img src=\"https://static.tigerbbs.com/804fc160873d5937d26f011ba169b9d9\" tg-width=\"640\" tg-height=\"426\"></p><p>彭斯的未来前景与特朗普密不可分，他的政治立场是十足的MAGA。但他也一直小心翼翼地与总统进行一些区分，而且今晚他很可能要再次这样做。（注：MAGA即“让美国再次伟大” (Make America Great Again)。这个竞选口号第一次是在1980年美国总统选举中被共和党总统候选人罗纳德·里根使用。后来2016年美国总统选举，又被共和党总统候选人特朗普使用。）</p><p>我们可以看看彭斯今年夏天在共和党全国代表大会上言论的重现，当时他说，特朗普“以自己的方式，按照自己的条件做事”。当彭斯说“有些人认为我们有点不同”时，这并不是在挖苦总统。但这也是彭斯在四年后能够回过头来指出的话，至少是作为某种分离的证据。</p><p><b>美国最高法院重设</b></p><p>特朗普的住院以及他周围共和党人的感染，这些事情把对巴雷特提名的关注转成了对白宫新冠病毒事件的研究。</p><p>如果彭斯今晚可以为特朗普做任何事情，那将是重新设置最高法院听证会作为竞选活动的焦点。共和党人认为，突出巴雷特可以为基础选民注入活力，并说服倾向保守的独立人士摆脱对特朗普性情或其他方面工作表现的保留意见。</p><p><img src=\"https://static.tigerbbs.com/2819781bbbacd68514bef338d989ff19\" tg-width=\"640\" tg-height=\"426\"></p><p>摆在眼前的是最高法院将在选举日一周后审理的一个削弱平价医疗法案的案件。</p><p>哈里斯将有机会打击彭斯关于政府取消医疗保健保护的做法。彭斯表示，他希望这项具有里程碑意义的裁决能够被推翻。</p><p>而彭斯也将获得一个机会，他可以就扩大最高法院的问题向哈里斯施压，因为她此前曾表示对这一问题持开放态度，但拜登拒绝解决这一问题。</p><p><b>生存和死亡是一个阶段</b></p><p>哈里斯已经赢得了第一轮辩论，尽管它甚至还没有开始。在辩论现场，有机玻璃将分隔开两位候选人，这清楚地提醒了公众特朗普政府无力控制新冠病毒大流行，甚至在白宫内部都没能控制。</p><p><img src=\"https://static.tigerbbs.com/4e0ddb0b609f120a1ac7d5c14a56f954\" tg-width=\"640\" tg-height=\"426\"></p><p>彭斯曾反对这样的设置，这是一个严重的误判。当然，对他来说，更好的结果是不竖立这种防止病毒传播的物理隔断。但在抵制（然后屈服）后他将付出双重代价——哈里斯不仅得到有机玻璃，而且还可以逼问彭斯为什么他反对这样的措施。</p><p>这并不是特朗普-彭斯选举团队想要进行的对话。而如果彭斯无法阻止组织者采取更严格的公共卫生措施，那么很难看到刚刚带着病毒离开医院的特朗普接下来在辩论中将如何做得更好。辩论组织者承诺表示将更加严格地执行戴口罩的规定。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/8b77771d013cef3fae5b989fd9a7fb26","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183475784","content_text":"美东时间10月7日晚9时许，美国副总统彭斯和民主党副总统候选人卡玛拉·哈里斯在盐湖城犹他大学举行首场、也是唯一一场副总统候选人电视辩论。辩论由《今日美国》华盛顿分社社长苏珊·佩奇主持。整个辩论围绕新冠疫情、医疗保健、经济、气候变化和外交政策等多个话题展开。就在刚刚，在彭斯和哈里斯的辩论结束后不久，美国总统特朗普发推称，“迈克·彭斯大赢！”美国大选今日看点：“蛰伏”的哈里斯单挑“特朗普的病毒防火墙”彭斯1.“蛰伏”的哈里斯自从成为拜登竞选伙伴后，这位加利福尼亚州参议员在很大程度上一直处于保密状态，这让她的支持者感到沮丧。一向以锋芒著称的哈里斯，在走上人生最高舞台后，为什么反而“蛰伏”了？周三和彭斯的辩论之夜，会是她在大选期间唯一光彩夺目的时刻吗？十年前哈里斯当选加州总检察长几年后的一天，哈里斯与几名助手坐在旧金山，有人猜测她有朝一日会成为总统。房间里顿时安静下来，半数的工作人员转向这位民主党新秀，想看看她会有什么反应。大家在讨论哈里斯将在国家舞台上扮演更大的角色。哈里斯说：“我永远不会想当总统。”据在场的一位人士回忆，她把这个国家的最高职位斥为 “可怕的工作”。然后，哈里斯以无可挑剔的时机，说出了笑点。短暂地停顿了一下，她说，“现在，副总统？这听起来并不那么糟糕。”去年，哈里斯曾经宣布参选总统，之后又退出初选，竞选成为二号人物成为非常适合哈里斯的选择。10月7日本周三晚上，她将与副总统迈克·彭斯（Mike Pence）对决，这或许是她竞选中最重要的时刻。乔·拜登选择哈里斯让民主党人兴奋不已。她帮助他以创纪录的速度筹集资金。她是拜登在密尔沃基、底特律和费城等摇摆州城市最高调的代理人，帮助他争取有色人种选民，包括非洲裔美国人和拉丁裔美国人。哈里斯单独或与拜登一起出现在电视广告中，这对副总统竞选人来说是罕见的。她在竞选活动推出的数字视频中担任明星，她已经成为77岁的拜登的流行文化使者，她与音乐偶像一起出现，参加面向非政治受众的播客，她穿着匡威Chuck Taylor运动鞋走下飞机的简短视频吸引了数百万人的观看。最不引人注目的副总统候选人不过，根据到目前为止的情况，拜登的避开聚光灯的竞选策略加上冠状病毒，已经使哈里斯成为最近记忆中最不引人注目的副总统竞选人。这让一些粉丝和盟友感到沮丧，他们希望选民看到更多的她，并认为这将有助于选票。当她走访餐馆、花店和理发店时，这些活动仅限于当地记者和旅行的记者，他们必须乘坐商业航班才能赶上这位副总统候选人。她的低调是二号人物的固有形象。而且可以肯定的是，她并不是唯一低调的人。拜登本人也保持着有限的公开日程，部分原因是冠状病毒，同时也因为，他希望选民针对特朗普的表现做出判断，而不是自己在竞选中的行为。伊利诺伊州库克县的州检察官金·福克斯说：“我知道有关副总统人选的传统想法是，你想要一个能让人们激动的人，一个不会造成伤害的人。我认为参议员哈里斯已经证明了，她不是那种你必须担心的人。当然我希望，在竞选的最后几天，他们能最大限度地发挥哈里斯的最大优势。”哈里斯最大的机会来自犹他州以及与副总统彭斯的辩论。长期以来，哈里斯的助手们一直把这场辩论视为展示她犀利风格的最大舞台。特朗普带着病毒在医院度过周末后重返白宫，这对于她是一个好消息。助手们说，她原计划把他的履历作为攻击的重点，由于总统宣称他的状况有所改善，那么进行这些攻击的时候可以毫不留情了。一位接近竞选团队的人士表示：“她可以对特朗普强硬，而不用担心（他的身体状况），我相信她会把彭斯当作起诉唐纳德·特朗普的证人。”本月晚些时候，在特朗普提名的最高法院大法官艾米·科尼·巴雷特(Amy Coney Barrett)的参议院听证会上，她可能会再次成为公众关注的焦点。哈里斯是司法委员会的成员，她对巴雷特的质询是听证会中最受期待的时刻。大家对哈里斯的渴望表明她在这几个月里取得了多大的进步。去年年底她退出初选时，她的支持率在30 - 35左右徘徊。在拜登选她做副总统之前，她为自己的政治回归奠定了基调。今年夏天，哈里斯卷土重来，成为支持华盛顿警察改革的最知名政治家之一。尽管她是副总统这个职位的早期领先者，一些拜登的盟友和她家乡州的民主党人警告竞选团队说，她将很难成为一个团队成员。哈里斯一直在努力克服这些看法，而拜登的竞选团队也在努力消除围绕这位候选人的任何戏剧性迹象。重返竞选活动后，哈里斯对谈论自己的角色非常谨慎，甚至在私人谈话中也是如此。但在她的行程开始安排之前，她向朋友和捐款人分享了她对这次比初选更轻松的行程安排的看法，表示松了一口气，并表示这给了她更多的时间来准备。低调中，支持率一路攀升最近几周，她的平均支持率攀升至45%左右，美国有线电视新闻网CNN周二公布的民调显示，支持率最高达到50%。尽管哈里斯在很大程度上避免了她在竞选活动中面临的审视，尤其是围绕她自己的履历，但她也没有完全避免这些小插曲。她因优先接受当地采访和非政治媒体的提问而受到批评。她拒绝在大选前表示是否会接受已获批准的冠状病毒疫苗，以表明她对特朗普的不信任，以及需要卫生专家的保证。这让她的竞选遭到了批评，有人称她反对针对该病毒的潜在治疗方法。哈里斯接受美国有线电视新闻网CNN采访，当她被问及是否会在选举前接种疫苗时说：“嗯，我认为这将是我们所有人面临的一个问题。”在另一次交流中，哈里斯被她和拜登宣布支持全国戴口罩后出现的问题搞得不知所措。拜登后来又说，总统授权使用口罩的权限尚不清楚，他自己也使用了“标准”的含糊语言。而在被问及扩大最高法院时，哈里斯含糊其辞，此前她对这个想法持开放态度。拜登说，在初选期间，他反对增加最高法院的大法官，但现在拒绝对此作出回答，他说，他说的任何话都会分散注意力。总而言之，从各方面来看，从她成为拜登副手的热门人选到目前为止，哈里斯已经成功地消除了反对者的担忧：她将使拜登黯然失色。一位竞选活动的捐助者说：“拜登是领导者，她正在强化这个信息。”严格执行竞选剧本哈里斯在初选中遇到了麻烦，她偏离了剧本——或者说根本没有剧本。早在2018年，当她在一次市政厅会议上被问及是否会拒绝企业或者企业游说者的捐款时，她说“这不一定”，然后她在仅仅几周后就改变了方向，选择不接受企业的钱。在初选期间，她竭力表达自己到底打算如何解决医保问题，而拜登竞选团队却驳斥了她提出的“万能”方案。但现在哈里斯的计划就是拜登的计划。而正如哈里斯在国会听证会上的表现所证明的那样，当她准备好了的时候，她可以是毁灭性的。上周，当特朗普住院时，哈里斯似乎不得不缓和她对总统的尖锐批评，这是一个微妙的任务。但现在，特朗普回到了白宫，而且开始在推特上怒发冲冠，没有人会指望哈里斯针对总统的态度会软下来。今晚是哈里斯上演的第一幕。她将在本月晚些时候的参议院听证会上对最高法院提名人艾米·科尼·巴雷特的预期质询中扮演第二个更重要的角色。2.成为防火墙的彭斯美国副总统迈克·彭斯今晚有政界最艰难的工作：为特朗普政府针对疫情施行的对策作辩护。彭斯有很多事例材料可以使用。新冠病毒大流行来势汹汹，总统自己也被感染，直到本周一才离开医院。白宫已经成为感染的热点。如果这些麻烦事情还不够，特朗普本周二取消了与众议院议长南希·佩洛西关于疫情救济方案的谈判，这一举动使得金融市场在他特朗普从医院回来的第一天就遭到打击。特朗普今晚需要从彭斯那里得到的是他一直需要的东西——对共和党人和右倾独立人士进行冷静和理性的解释，即无论情况多么混乱，他们所关心的保守派政策和最高法院提名人也都会和特朗普-彭斯的入场券一同出现。彭斯其实之前就做过这项工作。2016年，就在彭斯与蒂姆·凯恩辩论之前，特朗普威胁要起诉《纽约时报》，因为该报报道他逃避纳税(由于最近的报道，逃税这个话题很可能在今晚再次出现)。而特朗普在当时有最大的热点事件让彭斯来转移话题，话题内容包括从黑客主义到特朗普关于移民的言论。（注：蒂姆·凯恩现任美国参议员，是2016年民主党副总统的参选人。）彭斯的优势是，他领导了特朗普政府的新冠病毒专案组。目前已经有超过20万美国人死于新冠病毒，美国全国大部分地区也已经关闭封锁了几个月。彭斯领导的特朗普政府新冠病毒工作组的角色，使他成为舆论批评攻击政府应对此次疫情的主要目标。哈里斯将因白宫停滞不前、时而混乱的情况而抨击彭斯，并且舆论的力量是站在她这一边的。彭斯在这里没有什么好的选择。他可以指出特朗普感染病毒作为证据，证明病毒是可以战胜的，但是特朗普的病情细节仍然模糊不清，而且特朗普可以获得大多数美国人梦寐以求也得不到的医疗护理水平。他也可以责怪中国，说明情况可能会更糟。他还可以主张开放企业和学校，以减少疫情造成的长期的经济损失。但即使是彭斯最有效的手段——把话题转到其他地方，这次也很难执行，因为病毒是人们首要考虑的问题。盐湖城的情况非常严峻，以至于今天早上当地报纸关于辩论的报道占据了报纸头条，同时还有关于市长敦促恢复某些公共卫生限制的事情。展望2024年历史表明，今晚的副总统辩论几乎肯定不会影响这次选举的结果。但它可能会是下一次总统选举的预演。无论拜登还是特朗普获胜，哈里斯很可能会在下一次开放的民主党总统初选中成为领跑者，无论是2024年还是2028年。而彭斯呢？客气地说，他很稳定，虽然有时很无聊。但谁也不知道四年或者八年的特朗普政府之后，共和党人的性情会有什么变化。彭斯在共和党人中的支持率很稳固，他在基督教保守派中也得到一些支持。彭斯的未来前景与特朗普密不可分，他的政治立场是十足的MAGA。但他也一直小心翼翼地与总统进行一些区分，而且今晚他很可能要再次这样做。（注：MAGA即“让美国再次伟大” (Make America Great Again)。这个竞选口号第一次是在1980年美国总统选举中被共和党总统候选人罗纳德·里根使用。后来2016年美国总统选举，又被共和党总统候选人特朗普使用。）我们可以看看彭斯今年夏天在共和党全国代表大会上言论的重现，当时他说，特朗普“以自己的方式，按照自己的条件做事”。当彭斯说“有些人认为我们有点不同”时，这并不是在挖苦总统。但这也是彭斯在四年后能够回过头来指出的话，至少是作为某种分离的证据。美国最高法院重设特朗普的住院以及他周围共和党人的感染，这些事情把对巴雷特提名的关注转成了对白宫新冠病毒事件的研究。如果彭斯今晚可以为特朗普做任何事情，那将是重新设置最高法院听证会作为竞选活动的焦点。共和党人认为，突出巴雷特可以为基础选民注入活力，并说服倾向保守的独立人士摆脱对特朗普性情或其他方面工作表现的保留意见。摆在眼前的是最高法院将在选举日一周后审理的一个削弱平价医疗法案的案件。哈里斯将有机会打击彭斯关于政府取消医疗保健保护的做法。彭斯表示，他希望这项具有里程碑意义的裁决能够被推翻。而彭斯也将获得一个机会，他可以就扩大最高法院的问题向哈里斯施压，因为她此前曾表示对这一问题持开放态度，但拜登拒绝解决这一问题。生存和死亡是一个阶段哈里斯已经赢得了第一轮辩论，尽管它甚至还没有开始。在辩论现场，有机玻璃将分隔开两位候选人，这清楚地提醒了公众特朗普政府无力控制新冠病毒大流行，甚至在白宫内部都没能控制。彭斯曾反对这样的设置，这是一个严重的误判。当然，对他来说，更好的结果是不竖立这种防止病毒传播的物理隔断。但在抵制（然后屈服）后他将付出双重代价——哈里斯不仅得到有机玻璃，而且还可以逼问彭斯为什么他反对这样的措施。这并不是特朗普-彭斯选举团队想要进行的对话。而如果彭斯无法阻止组织者采取更严格的公共卫生措施，那么很难看到刚刚带着病毒离开医院的特朗普接下来在辩论中将如何做得更好。辩论组织者承诺表示将更加严格地执行戴口罩的规定。","news_type":1},"isVote":1,"tweetType":1,"viewCount":2658,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":303051057,"gmtCreate":1602834934679,"gmtModify":1703828107110,"author":{"id":"3547492843908436","authorId":"3547492843908436","name":"Alicent","avatar":"https://static.tigerbbs.com/0a7b09bfad47e4ab0b7a96cdfaec4d6d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547492843908436","authorIdStr":"3547492843908436"},"themes":[],"htmlText":"说苹果创新缺失的恐怕是准备抄底的吧","listText":"说苹果创新缺失的恐怕是准备抄底的吧","text":"说苹果创新缺失的恐怕是准备抄底的吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/303051057","repostId":"2075034139","repostType":2,"repost":{"id":"2075034139","kind":"news","weMediaInfo":{"introduction":"华商人物与企业新媒体第一殿堂。","home_visible":1,"media_name":"华商韬略","id":"27","head_image":"https://static.tigerbbs.com/08f34cc62ee54134a6a68fe6538c26f8"},"pubTimestamp":1602834508,"share":"https://www.laohu8.com/m/news/2075034139?lang=&edition=full","pubTime":"2020-10-16 15:48","market":"us","language":"zh","title":"库克开始学习贾跃亭，苹果已处于危险境地","url":"https://stock-news.laohu8.com/highlight/detail?id=2075034139","media":"华商韬略","summary":"苹果已经处于高利润、高市值和不能冒险大创新夹层的危险处境里。","content":"<p>文 | 华商韬略 阿团</p>\n<p>10月14号，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>新品发布会举行，让人们看到了“创新”失色的iPhone。</p>\n<p>2019年2月，华为和<a href=\"https://laohu8.com/S/SMSN.UK\">三星</a>发布了折叠屏手机华为Mate X与三星Fold；2020年，华为和三星又推出了折叠屏二代产品。</p>\n<p>但苹果却在新手机的形态探索上显得格外沉默。</p>\n<p>伴随iPhone创新缺失的，是出货量的下滑和在全球手机市场的利润比重的下降。</p>\n<p>苹果公司50%以上的营收都来自iPhone业务，iPhone硬件的高溢价是苹果公司重要的利润来源，苹果不可能投入太多成本在入门版iPhone上。</p>\n<p>越来越多的手机厂商，通过学习iPhone的方式，蚕食它的市场。</p>\n<p>硬件方面的创新更是接近枯竭，最明显的一点便是，这一次发布会上，iPhone开始学习其他厂商比芯片跑分了。要知道，高傲苹果可一直是拿来被别人比的。</p>\n<p>苹果已经处于高利润、高市值和不能冒险大创新夹层的危险处境里。</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/114fa59c7eeefeeec1550f742a7f456e\" tg-width=\"578\" tg-height=\"300\"><span>图片来源于网络， 侵权必删</span></p>\n<p>除了硬件库克将目光放到用户身上，尝试用服务收入和连带销售，来维持公司的利润和市值成长。</p>\n<p>比如，2019年3月26日，苹果在Apple Care、Apple Pay、iCloud和Apple Music等原有服务的基础上，进一步推出了新闻订阅服务Apple News+以及流媒体视频订阅服务Apple TV+。</p>\n<p>这些调整也是有效的。数据显示，2019财年，苹果的服务业务所占营收比重就得到了快速提升，一到四季度分别为12.9%、19.7%、21.3%、19.5%。</p>\n<p>再比如，砍掉“五福一安”和耳机孔，也是为了带动可穿戴设备及配件销售增长。</p>\n<p>这不禁让人想起曾经红极一时的互联网品牌——乐视，和贾跃亭的生态化反。</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a04ba187e8ea653aac09dcd2b4ff5388\" tg-width=\"580\" tg-height=\"325\"><span>图片来源于网络， 侵权必删</span></p>\n<p>乐视成立于2004年，创始人贾跃亭利用视频网站的利好形势，一路频频冠名，转播，投资。</p>\n<p>名气和股价的暴涨带来的是野心的极速暴涨，贾布斯企图打造一个大陆版的TVB，即自己投资拍电影拍电视，在自己的网站上播放。</p>\n<p>乐视的生态是由视频网站扩展形成，包括：视频网站、电视、手机、体育、汽车等。贾跃亭有个幻想：通过生态产业之间的互联、共享和传递，让消费者从“平台-内容-终端”都选择乐视产品。</p>\n<p>由此产生了内容+生态的理念，但内容有了，生态呢？</p>\n<p>生态之间相互依存，必须要有一块强大的业务根基，为其它板块提供持续、循环、充足的造血功能，才会形成企业的良性发展。</p>\n<p>乐视的生态意味着它需要不断的地资金投入，在缺乏足够资金支持的情况下，贾跃亭的失败也就不足为奇了。</p>\n<p>若不是贾跃亭为梦想窒息搞起了汽车把自己窒息了，那么乐视那一套也许也会成功。今天的苹果，越来越像当年贾跃亭的设想。</p>\n<p>可以贾跃亭当时梦太大，入错行了。</p>\n<p>目前，手机市场遇冷已经成为行业共识，库克却学贾跃亭那套，不知道苹果未来何去何从……</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>库克开始学习贾跃亭，苹果已处于危险境地</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n库克开始学习贾跃亭，苹果已处于危险境地\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/27\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/08f34cc62ee54134a6a68fe6538c26f8);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">华商韬略 </p>\n<p class=\"h-time\">2020-10-16 15:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>文 | 华商韬略 阿团</p>\n<p>10月14号，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>新品发布会举行，让人们看到了“创新”失色的iPhone。</p>\n<p>2019年2月，华为和<a href=\"https://laohu8.com/S/SMSN.UK\">三星</a>发布了折叠屏手机华为Mate X与三星Fold；2020年，华为和三星又推出了折叠屏二代产品。</p>\n<p>但苹果却在新手机的形态探索上显得格外沉默。</p>\n<p>伴随iPhone创新缺失的，是出货量的下滑和在全球手机市场的利润比重的下降。</p>\n<p>苹果公司50%以上的营收都来自iPhone业务，iPhone硬件的高溢价是苹果公司重要的利润来源，苹果不可能投入太多成本在入门版iPhone上。</p>\n<p>越来越多的手机厂商，通过学习iPhone的方式，蚕食它的市场。</p>\n<p>硬件方面的创新更是接近枯竭，最明显的一点便是，这一次发布会上，iPhone开始学习其他厂商比芯片跑分了。要知道，高傲苹果可一直是拿来被别人比的。</p>\n<p>苹果已经处于高利润、高市值和不能冒险大创新夹层的危险处境里。</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/114fa59c7eeefeeec1550f742a7f456e\" tg-width=\"578\" tg-height=\"300\"><span>图片来源于网络， 侵权必删</span></p>\n<p>除了硬件库克将目光放到用户身上，尝试用服务收入和连带销售，来维持公司的利润和市值成长。</p>\n<p>比如，2019年3月26日，苹果在Apple Care、Apple Pay、iCloud和Apple Music等原有服务的基础上，进一步推出了新闻订阅服务Apple News+以及流媒体视频订阅服务Apple TV+。</p>\n<p>这些调整也是有效的。数据显示，2019财年，苹果的服务业务所占营收比重就得到了快速提升，一到四季度分别为12.9%、19.7%、21.3%、19.5%。</p>\n<p>再比如，砍掉“五福一安”和耳机孔，也是为了带动可穿戴设备及配件销售增长。</p>\n<p>这不禁让人想起曾经红极一时的互联网品牌——乐视，和贾跃亭的生态化反。</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a04ba187e8ea653aac09dcd2b4ff5388\" tg-width=\"580\" tg-height=\"325\"><span>图片来源于网络， 侵权必删</span></p>\n<p>乐视成立于2004年，创始人贾跃亭利用视频网站的利好形势，一路频频冠名，转播，投资。</p>\n<p>名气和股价的暴涨带来的是野心的极速暴涨，贾布斯企图打造一个大陆版的TVB，即自己投资拍电影拍电视，在自己的网站上播放。</p>\n<p>乐视的生态是由视频网站扩展形成，包括：视频网站、电视、手机、体育、汽车等。贾跃亭有个幻想：通过生态产业之间的互联、共享和传递，让消费者从“平台-内容-终端”都选择乐视产品。</p>\n<p>由此产生了内容+生态的理念，但内容有了，生态呢？</p>\n<p>生态之间相互依存，必须要有一块强大的业务根基，为其它板块提供持续、循环、充足的造血功能，才会形成企业的良性发展。</p>\n<p>乐视的生态意味着它需要不断的地资金投入，在缺乏足够资金支持的情况下，贾跃亭的失败也就不足为奇了。</p>\n<p>若不是贾跃亭为梦想窒息搞起了汽车把自己窒息了，那么乐视那一套也许也会成功。今天的苹果，越来越像当年贾跃亭的设想。</p>\n<p>可以贾跃亭当时梦太大，入错行了。</p>\n<p>目前，手机市场遇冷已经成为行业共识，库克却学贾跃亭那套，不知道苹果未来何去何从……</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/114fa59c7eeefeeec1550f742a7f456e","relate_stocks":{"AAPL":"苹果"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2075034139","content_text":"文 | 华商韬略 阿团\n10月14号，苹果新品发布会举行，让人们看到了“创新”失色的iPhone。\n2019年2月，华为和三星发布了折叠屏手机华为Mate X与三星Fold；2020年，华为和三星又推出了折叠屏二代产品。\n但苹果却在新手机的形态探索上显得格外沉默。\n伴随iPhone创新缺失的，是出货量的下滑和在全球手机市场的利润比重的下降。\n苹果公司50%以上的营收都来自iPhone业务，iPhone硬件的高溢价是苹果公司重要的利润来源，苹果不可能投入太多成本在入门版iPhone上。\n越来越多的手机厂商，通过学习iPhone的方式，蚕食它的市场。\n硬件方面的创新更是接近枯竭，最明显的一点便是，这一次发布会上，iPhone开始学习其他厂商比芯片跑分了。要知道，高傲苹果可一直是拿来被别人比的。\n苹果已经处于高利润、高市值和不能冒险大创新夹层的危险处境里。\n图片来源于网络， 侵权必删\n除了硬件库克将目光放到用户身上，尝试用服务收入和连带销售，来维持公司的利润和市值成长。\n比如，2019年3月26日，苹果在Apple Care、Apple Pay、iCloud和Apple Music等原有服务的基础上，进一步推出了新闻订阅服务Apple News+以及流媒体视频订阅服务Apple TV+。\n这些调整也是有效的。数据显示，2019财年，苹果的服务业务所占营收比重就得到了快速提升，一到四季度分别为12.9%、19.7%、21.3%、19.5%。\n再比如，砍掉“五福一安”和耳机孔，也是为了带动可穿戴设备及配件销售增长。\n这不禁让人想起曾经红极一时的互联网品牌——乐视，和贾跃亭的生态化反。\n图片来源于网络， 侵权必删\n乐视成立于2004年，创始人贾跃亭利用视频网站的利好形势，一路频频冠名，转播，投资。\n名气和股价的暴涨带来的是野心的极速暴涨，贾布斯企图打造一个大陆版的TVB，即自己投资拍电影拍电视，在自己的网站上播放。\n乐视的生态是由视频网站扩展形成，包括：视频网站、电视、手机、体育、汽车等。贾跃亭有个幻想：通过生态产业之间的互联、共享和传递，让消费者从“平台-内容-终端”都选择乐视产品。\n由此产生了内容+生态的理念，但内容有了，生态呢？\n生态之间相互依存，必须要有一块强大的业务根基，为其它板块提供持续、循环、充足的造血功能，才会形成企业的良性发展。\n乐视的生态意味着它需要不断的地资金投入，在缺乏足够资金支持的情况下，贾跃亭的失败也就不足为奇了。\n若不是贾跃亭为梦想窒息搞起了汽车把自己窒息了，那么乐视那一套也许也会成功。今天的苹果，越来越像当年贾跃亭的设想。\n可以贾跃亭当时梦太大，入错行了。\n目前，手机市场遇冷已经成为行业共识，库克却学贾跃亭那套，不知道苹果未来何去何从……","news_type":1},"isVote":1,"tweetType":1,"viewCount":1899,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":380424190284304,"gmtCreate":1733918362325,"gmtModify":1733918363995,"author":{"id":"3547492843908436","authorId":"3547492843908436","name":"Alicent","avatar":"https://static.tigerbbs.com/0a7b09bfad47e4ab0b7a96cdfaec4d6d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547492843908436","authorIdStr":"3547492843908436"},"themes":[],"htmlText":"为何不敢把连锁酒店的名字写出来？","listText":"为何不敢把连锁酒店的名字写出来？","text":"为何不敢把连锁酒店的名字写出来？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/380424190284304","repostId":"2484620377","repostType":2,"isVote":1,"tweetType":1,"viewCount":82,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":263861218226416,"gmtCreate":1705454887797,"gmtModify":1705454889365,"author":{"id":"3547492843908436","authorId":"3547492843908436","name":"Alicent","avatar":"https://static.tigerbbs.com/0a7b09bfad47e4ab0b7a96cdfaec4d6d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547492843908436","authorIdStr":"3547492843908436"},"themes":[],"htmlText":"文章顶部列出的两个股票代码和这家公司毫无关系","listText":"文章顶部列出的两个股票代码和这家公司毫无关系","text":"文章顶部列出的两个股票代码和这家公司毫无关系","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/263861218226416","repostId":"2402156309","repostType":2,"isVote":1,"tweetType":1,"viewCount":731,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":221185427062792,"gmtCreate":1695040073723,"gmtModify":1695043301900,"author":{"id":"3547492843908436","authorId":"3547492843908436","name":"Alicent","avatar":"https://static.tigerbbs.com/0a7b09bfad47e4ab0b7a96cdfaec4d6d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547492843908436","authorIdStr":"3547492843908436"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RDHL\">$Redhill Biopharma Ltd(RDHL)$&nbsp;</a>老虎证券里的资讯没有 Yahoo Finance 里的股票新闻及时。 这支股票今天获得美国 FDA 批准用于治疗幽门螺旋杆菌的简化用药方案","listText":"<a href=\"https://laohu8.com/S/RDHL\">$Redhill Biopharma Ltd(RDHL)$&nbsp;</a>老虎证券里的资讯没有 Yahoo Finance 里的股票新闻及时。 这支股票今天获得美国 FDA 批准用于治疗幽门螺旋杆菌的简化用药方案","text":"$Redhill Biopharma Ltd(RDHL)$ 老虎证券里的资讯没有 Yahoo Finance 里的股票新闻及时。 这支股票今天获得美国 FDA 批准用于治疗幽门螺旋杆菌的简化用药方案","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/221185427062792","isVote":1,"tweetType":1,"viewCount":1544,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":397129681,"gmtCreate":1608211177443,"gmtModify":1703851787936,"author":{"id":"3547492843908436","authorId":"3547492843908436","name":"Alicent","avatar":"https://static.tigerbbs.com/0a7b09bfad47e4ab0b7a96cdfaec4d6d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3547492843908436","authorIdStr":"3547492843908436"},"themes":[],"htmlText":"截图里的行情如何能看到？如何能看到粉票市场的盘前盘后？","listText":"截图里的行情如何能看到？如何能看到粉票市场的盘前盘后？","text":"截图里的行情如何能看到？如何能看到粉票市场的盘前盘后？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/397129681","repostId":"1113876805","repostType":4,"repost":{"id":"1113876805","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1608210883,"share":"https://www.laohu8.com/m/news/1113876805?lang=&edition=full","pubTime":"2020-12-17 21:14","market":"us","language":"zh","title":"瑞幸咖啡盘前大涨44%，1.8亿美元与SEC达成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=1113876805","media":"老虎资讯综合","summary":"12月17日，$瑞幸咖啡(LK)$在美国粉单市场盘前大涨44%。老虎综合账户可以交易在粉单市场的瑞幸咖啡股票。\n\n\n\n美国证券交易委员会（SEC）发布消息称，与$瑞幸咖啡(LK)$达成和解，后者同意针对造假指控支付1.8亿美元（约合人民币11.8亿元）罚款。\n\nSEC表示，从2019年4月至2020年1月，瑞幸通过关联方虚假交易伪造了超过3亿美元的销售额，从债券和股票投资者那里筹集了超过8.64亿美元资金。不过，这项和解协议需要得到法院的同意才能生效。\n\n截至目前，瑞幸面临的各项处罚总金额超过12亿元人民币。","content":"<p>12月17日，<a href=\"https://laohu8.com/S/LK\">瑞幸咖啡</a>在美国粉单市场盘前大涨44%。<b>老虎综合账户可以交易在粉单市场的瑞幸咖啡股票。</b></p><p><img src=\"https://static.tigerbbs.com/bfe41adbad20b5a5d4260d2efba48813\" tg-width=\"369\" tg-height=\"800\"></p><p>美国证券交易委员会（SEC）发布消息称，与<a href=\"https://laohu8.com/S/LK\">瑞幸咖啡</a>达成和解，后者同意针对造假指控支付1.8亿美元（约合人民币11.8亿元）罚款。</p><p>SEC表示，从2019年4月至2020年1月，瑞幸通过关联方虚假交易伪造了超过3亿美元的销售额，从债券和股票投资者那里筹集了超过8.64亿美元资金。不过，这项和解协议需要得到法院的同意才能生效。</p><p>截至目前，瑞幸面临的各项处罚总金额超过12亿元人民币。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>瑞幸咖啡盘前大涨44%，1.8亿美元与SEC达成和解</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n瑞幸咖啡盘前大涨44%，1.8亿美元与SEC达成和解\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-12-17 21:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>12月17日，<a href=\"https://laohu8.com/S/LK\">瑞幸咖啡</a>在美国粉单市场盘前大涨44%。<b>老虎综合账户可以交易在粉单市场的瑞幸咖啡股票。</b></p><p><img src=\"https://static.tigerbbs.com/bfe41adbad20b5a5d4260d2efba48813\" tg-width=\"369\" tg-height=\"800\"></p><p>美国证券交易委员会（SEC）发布消息称，与<a href=\"https://laohu8.com/S/LK\">瑞幸咖啡</a>达成和解，后者同意针对造假指控支付1.8亿美元（约合人民币11.8亿元）罚款。</p><p>SEC表示，从2019年4月至2020年1月，瑞幸通过关联方虚假交易伪造了超过3亿美元的销售额，从债券和股票投资者那里筹集了超过8.64亿美元资金。不过，这项和解协议需要得到法院的同意才能生效。</p><p>截至目前，瑞幸面临的各项处罚总金额超过12亿元人民币。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/3d12f820102df1859c1d25e4011ee104","relate_stocks":{"LKNCY":"瑞幸咖啡"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113876805","content_text":"12月17日，瑞幸咖啡在美国粉单市场盘前大涨44%。老虎综合账户可以交易在粉单市场的瑞幸咖啡股票。美国证券交易委员会（SEC）发布消息称，与瑞幸咖啡达成和解，后者同意针对造假指控支付1.8亿美元（约合人民币11.8亿元）罚款。SEC表示，从2019年4月至2020年1月，瑞幸通过关联方虚假交易伪造了超过3亿美元的销售额，从债券和股票投资者那里筹集了超过8.64亿美元资金。不过，这项和解协议需要得到法院的同意才能生效。截至目前，瑞幸面临的各项处罚总金额超过12亿元人民币。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}